Investing.com - Merck reported on Friday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €1.57 on revenue of €4.60B. Analysts polled by Investing.com anticipated EPS of €1.58 on revenue of €4.51B.
Merck shares are up 14% from the beginning of the year, still down 11.18% from its 52 week high of €149.95 set on January 19. They are outperforming the STOXX 600 which is up 3.23% from the start of the year.
Merck shares lost 100.00% in pre-market trade following the report.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings beat by Bayer on February 25, who reported EPS of €1.32 on revenue of €10B, compared to forecasts EPS of €1.26 on revenue of €10.13B.
Fresenius SE had beat expectations on February 22 with fourth quarter EPS of €0.88 on revenue of €9.3B, compared to forecast for EPS of €0.8426 on revenue of €9.1B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar